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Abstract 
TRIBBLES pseudokinases (TRIB1, TRIB2 and TRIB3) are important regulators of 
normal and malignant haemopoiesis. The relative abundance of each TRIBBLES 
family member may be important for distinct oncogenic or tumour suppressor 
functions. We map the expression profiles of TRIB1, TRIB2 and TRIB3 in human 
and murine haemopoietic stem, progenitor and mature cells and in human 
leukaemia datasets. Our data show that TRIB1-TRIB2 have an inverse expression 
relationship in normal haemopoiesis whereas TRIB1-TRIB3 have a positive 
correlation. We reveal that TRIB3 expression is high in the dormant 
haemopoietic stem cell (HSC) population, implicating a novel role for TRIB3 in 
stem cell quiescence. These analyses support a non-redundant role for each 
TRIBBLES member during normal haemopoietic differentiation. We show that 
TRIB1-TRIB2 display a significant negative correlation in myelodysplastic 
syndrome (MDS) and acute myeloid leukaemia (AML) subtypes, but not in acute 
lymphoid leukaemia (ALL). This inverse relationship is specific to certain 
subtypes of AML. A positive correlation exists in different leukaemia subtypes 
between TRIB1-TRIB3. The TRIB1-TRIB2 and TRIB1-TRIB3 correlations are 
consistent with a correlative relationship with C/EBP transcription factor family 
members. Our results have implications for the development of strategies to 
therapeutically target these genes in different types of leukaemia.  
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Introduction 
TRIBBLES proteins are pseudokinases that bind and modulate the activity of 
several signalling molecules, including kinases, phosphatases, transcription 
factors and components of the ubiquitin proteasome system. From their first 
identification in mammalian cells, TRIBBLES have been recognised as inducible 
genes, modulated by a wide range of mitogens and stressors, and associated 
with downstream regulation of key signalling pathways, including those of AKT, 
ATF4, NF-kB and MAPKs(1-3). TRIBBLES pseudokinases are involved in different 
disease pathways and in many cancer types, including solid tumours, such as 
melanoma, liver and lung cancer (4,5). The generation of Tribbles deficient 
mice has revealed important aspects of the diverse roles of the TRIBBLES 
proteins(6-10). Mammalian TRIBBLES proteins regulate differentiation and 
survival of haemopoietic cells across different lineages and are frequently 
deregulated in acute leukaemia(11).  
The evolution of three mammalian family members, TRIB1, TRIB2 and TRIB3, was 
suggested to be the result of gene duplications, from the ancestor TRIB2 gene, 
that led to the acquisition of specialized protein functions and non-redundant 
biological roles(5). It has been shown that the three pseudokinases have both 
shared and unique biological functions, during normal and malignant 
haemopoiesis. TRIBBLES pseudokinases act as molecular scaffolds for the 
assembly and regulation of signalling modules and also as templates for 
substrate-directed ubiquitination. The TRIB pseudokinase domain is fused to a C-
terminal tail containing binding sites for MAPK Kinase 1 (MEK1) (and other MAPKK 
dual-specificity kinases) and for the ubiquitin E3 ligase Constitutive 
Photomorphogenic Protein 1 (COP1)(12-14). The TRIB signalling output is 
controlled through the binding and modulation of active kinases e.g. MEK/MAPK, 
and through destruction of TRIB ‘substrates’ that interact via the pseudokinase 
domain e.g. Cell Division Cycle 25 (CDC25), Acetyl CoA carboxylase (ACC), and 
CCAAT/enhancer-binding protein (C/EBP) transcription factors(14-18). Structural 
biologists have confirmed the mechanistic cellular model and demonstrated that 
TRIBs C-terminal tail motif binds competitively in cis to both its pseudokinase 
domain and partner ubiquitin E3 ligases, such as COP1(19-21).  
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Recently it has been shown that oncogenic functions of TRIBBLES also include 
upregulation of anti-apoptotic B-cell lymphoma 2 (BCL2) levels, stabilization of 
Promyelocytic leukemia-Retinoic acid receptor α (PML-RARα), and p53-dependent 
upregulation of c-MYC, driving drug resistance(22-24). In contrast, tumour 
suppressor activity for TRIBBLES has been identified in AML and ALL, linked with 
defective p38 MAPK signalling(7,25,26). Thus, TRIBBLES pseudokinases appear to 
exert both oncogenic and tumour suppressive roles in different types of 
leukaemias. We do not yet know how these opposing roles for TRIB1, TRIB2 and 
TRIB3 are regulated, or when they manifest.  
In this study, we interrogate publicly available expression data for TRIB1, TRIB2 
and TRIB3 in human and murine normal haemopoietic cells, and leukaemia 
datasets using the BloodSpot platform (Figure 1 and Supplemental Table S1). 
We reveal specific inverse and correlative relationships between TRIBBLES family 
members in normal and malignant haemopoiesis. We correlate TRIB1 and TRIB3 
positively, whereas TRIB2 correlates negatively, with C/EBP family members. 
Known (e.g. E2F(27)) and putative transcription factors(5) that control TRIBBLES 
expression distinguish the TRIB members in normal and malignant cells. Our 
analyses support that individual TRIBBLES have non-redundant lineage-specific 
functions during haemopoiesis. We provide evidence of a significant inverse 
relationship between TRIB1 and TRIB2 in the specification of different blood 
lineages and in AML inferred by their expression. We also identify high 
expression of TRIB3 in the highly self-renewing, dormant HSC population. 
Together our analyses show that TRIBBLES expression is differentially modulated 
in leukaemia and the direction (high or low expression) and the extent of 
expression variation is dependent on the oncogenic background of the malignant 
cells. 
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Results 
Inverse relationship between TRIBBLES physiological expression levels in the 
haemopoietic system  
To provide a comprehensive insight into TRIBBLES expression patterns in normal 
haemopoiesis, we interrogated the publicly available datasets of gene 
expression, using the bioinformatic platform BloodSpot, which combines 
expression data from curated microarray or RNA-Seq analyses of normal and 
malignant haemopoietic cells, at various developmental stages(28) (Figure 1). 
Firstly, we looked at curated human microarray data of the main blood 
populations, including haemopoietic stem cells (HSCs), early haemopoietic 
progenitor cells (HPCs), common myeloid progenitor cells (CMPs), granulocyte 
macrophage progenitors (GMPs), megakaryocyte-erythroid progenitors (MEPs), 
and differentiated myeloid and lymphoid cells (monocytes, polymorphonuclear 
cells (PMN) from PB, CD4+ and CD8+ T-cells, and natural killer (NK) cells) (Figure 
2, identified and isolated as described in Supplemental Table 2). The gene 
expression data provided by BloodSpot was combined from independent datasets 
(GSE17054(29), GSE19599(30), GSE11864(31) and E-MEXP-1242(32)) and was 
normalised and batch corrected, as described in (33). We found that both TRIB1 
and TRIB2 had up to 6 Log2 expression units (eu) variation between their highest 
and lowest expressing cell types. Interestingly, they followed an inverse 
expression pattern. TRIB1 was high in the myeloid lineage, with the highest 
expression value in differentiated CD14+ monocytes (9.5 eu), and expressed at 
low levels in the lymphoid cells, MEPs, and with lowest expression in the NK cells 
(3.7 eu). Conversely, TRIB2 levels were high in the lymphoid populations, 
including B-, T- and NK cells (all ~10 eu), MEPs (10.5 eu), and low in 
differentiated myeloid cells (PMN and monocytes) (~4-5 eu). By contrast, TRIB3 
expression ranged within less than 2 eu, between 5.7 and 7 eu, with the highest 
expression values in the HSCs, CMPs, and GMPs and least expression in the T-cell 
compartment. Overall these data suggest that physiological TRIB1 expression is 
important for differentiated myeloid cells, TRIB2 for lymphoid and erythroid 
lineages, and TRIB3 has a potential function in the more primitive stem and 
myeloid progenitor populations. 
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To correlate human expression data with the murine haemopoietic system, we 
used BloodSpot and retrieved gene expression data combined and batch 
corrected from two murine datasets of normal haemopoietic cells (GSE14833(34) 
and GSE6506(35)). The samples in this analysis included stem cells, progenitors, 
committed and differentiated populations of the myeloid, lymphoid and 
erythroid compartments, identified and isolated as described in Supplemental 
Table 3. Trib1 expression during murine haemopoiesis followed a pattern similar 
to that observed in the human cells (Figure 3A, and Supplemental Figure S1). 
Trib1 was low in the stem cells, lineage progenitors, erythroid, NK and T-cell 
lineages, and in differentiated B-cells, but highly expressed in the myeloid 
differentiated monocytes and granulocytes. Similar to expression data from 
human cells, murine Trib2 expression levels were high in the T-, B- and erythroid 
cells lineages, and low in differentiated myeloid cells (Figure 3B, and 
Supplemental Figure S1). During T cell development, Trib2 expression increased 
~2 eu from the CLPs (4.2 eu) to the Early T-cell progenitor cells (ETP) (6.5 eu), 
peaked in differentiated single positive CD4+ and CD8+ T-cells (10.2 and 8.9 eu), 
and was slightly lower in their activated counterparts (populations activated 
with the lymphocyte mitogen Concanavalin A). During B-cell development, Trib2 
expression was low at early stages (Pro-B cells 4.4 eu), high in Pre-B and IgM+ B-
cells (~10 eu), and reached ~8.5 eu in differentiated B-cells. The highest Trib2 
expression values were detected in the MkE precursor stage (11.2 eu) and were 
progressively lower in the derived populations of the erythroid lineage. 
Moreover, Trib2 was low in MkP cells (4.7 eu). The only cells that showed 
contradictory Trib2 levels between human and murine data was in NK cells, 
where murine NK cells had low Trib2 expression in contrast to high levels 
observed in human cells. Murine Trib3 expression was high in the LT-HSCs, as 
observed in human cells, and in IgM+ B-cells, and low in the other 
compartments, including differentiated myeloid, erythroid, and lymphoid cells 
(Figure 3C, and Supplemental Figure S1). Higher Trib3 expression was observed 
in activated T-cells (cells not present in the human datasets), compared to their 
naïve counterparts and other cell populations. To investigate further the 
expression of the three Tribbles genes in the stem cell compartment, we 
interrogated a dataset of murine active and dormant LT-HSCs(36). Interestingly, 
analysis with the GEO2R online platform revealed that only Trib3 was included in 
the top 250 differentially expressed genes, with higher expression in the 
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dormant LT-HSCs, compared to the active counterpart (Figure 3D). These 
expression data may indicate a role for Trib3 in regulating HSCs, and specifically 
HSC dormancy. 
To more comprehensively address Tribbles expression in immune cells, murine 
Tribbles expression was evaluated in the microarray datasets of the ImmGen 
project(37-40), using BloodSpot (Figure 4). ImmGen represent a vast collection 
of expression data of over 250 FACS sorted haemopoietic populations from both 
myeloid and lymphoid lineages, innate and adaptive immune systems. For the 
purpose of our analysis, we focused on some key populations, among those 
available in BloodSpot, including those listed in Supplemental Table 4. In line 
with the previous results in both murine and human samples (Figure 2 and 3), 
Trib1 had the highest expression in differentiated myeloid cells (monocytes 8.9 
and granulocytes 9.5 eu). Again, Trib2 showed the opposite lineage specific 
expression, with highest expression in the T- and B-cells lineages (ranging from 
9.3 to 10.2 eu), and low in the myeloid compartment. Both Trib1 and Trib2 
displayed high expression variability across different cell types (between 6.1 and 
10.2 eu for Trib2, and between 6.3 and 9.5 eu for Trib1). Trib3 expression range 
was again relatively narrow (from 6.6 to 7.2 eu), with high expression in the 
stem cell compartment. Once more we see an inverse relationship between 
Trib1 and Trib2 in the mature B cells, with high Trib2 expression specifically in 
GC B cells (9.2 eu). Interestingly, the expression of all three mammalian 
Tribbles in CD4+CD25+FOXP3+ T-regulatory cells was higher than immature 
double-positive T-cells (Figure 4).  
Furthermore, we looked at Tribbles mRNA expression in murine haemopoietic 
cells as measured by RNA-Seq (GSE60101(41)) and processed in the BloodSpot 
platform (Supplemental Figure S2, Supplemental Table 5). RNA-Seq data has 
several advantages over the microarray technology, including a higher signal-to-
noise ratio and the possibility to detect a broader range of expression levels. 
Trib1 was highly expressed in differentiated granulocytes (7 eu), moderately 
expressed in the stem and lymphoid compartments, and expressed at low levels 
in the erythroid lineage, similar to human and murine microarray data. Trib2 
was highly expressed in the T cells, with the highest expression values in CD4+ T-
cells (6.9 eu), aswell as B cells, and MEPs, and progressively decreasing from 
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CMPs to GMPs to the lowest level in differentiated myeloid cells (<1 eu) all in 
line with the murine microarray results. An interesting contrast to the 
microarray data is the relatively high expression of Trib2 in the murine HSC 
compartment in the RNA-seq data (Supplemental Figure S2). This has been 
confirmed, with qRT-PCR data showing higher Trib2 expression in HSCs 
compared to GMPs(22). Trib3 expression was overall lower in haemopoietic cells 
compared to Trib1 and Trib2, with the highest expression values found in the 
stem cells, matching the microarray data. 
Significant negative correlation between TRIB1 and TRIB2 in human AML 
subtypes  
We next interrogated the relationship of Tribbles expression across leukaemias 
and in subtypes of human AML. Firstly, we examined the expression of the 
TRIB1, TRIB2 and TRIB3 genes, individually, across several leukaemia types 
collected and analysed from 5 independent studies (including data from 
GSE14468(42), GSE61804(43), GSE15434(44), the Leukemia MILE study 
(GSE13159(45)) and The Cancer Genome Atlas(46), TCGA, database, and 
collectively referred to as BloodPool(28), Figure 1). TRIBBLES expression 
patterns were analysed alongside normal haemopoietic populations at various 
differentiation stages (GSE42519(47)) (Figure 5, Supplemental Figure S3 and 
Supplemental Table S6). Visualization of the three genes’ expression patterns, 
in the hierarchical plot format, allows us to compare the expression of each AML 
subtype with respect to several different normal haemopoietic lineages. TRIB1 
expression is high across most AML groups, with respect to normal HSCs and 
myeloid progenitor cells, but the expression rarely reaches the levels observed 
in normal differentiated myeloid cells which we have shown are the cells that 
express the highest levels of TRIB1. Similarly, in most AML cases TRIB2 
expression does not reach levels comparable to normal MEP cells which we 
showed express high levels of TRIB2. AML subtypes including deletions in 
chromosomes 5, del(5q), or 7, del(7q)/7q-, display higher expression than in 
normal HSCs or GMP, whereas in other AML groups TRIB2 expression is lower than 
in normal GMP, e.g. AML subtypes with translocations of chromosomes 9 or 11. 
Finally, TRIB3 expression range is again much narrower than TRIB1 and TRIB2, 
and most AML subtypes have lower median TRIB3 expression than normal HSC, 
CMP and GMP cells. Therefore, the comparison to control normal populations is 
 
 
 9 
important for considering whether TRIB levels are high or low in different AML 
subtypes.  
We calculated the Pearson r correlation coefficient, as a measure of gene 
correlation between TRIB1, TRIB2 and TRIB3 given their divergent expression in 
AML as well as in normal haemopoiesis. Firstly, in normal cells (all normal 
populations pooled), TRIB2 is inversely correlated to both TRIB1 and TRIB3, and 
TRIB1-TRIB3 are positively correlated within each other (Figure 6Ai). Indeed, 
the Log2 expression values of TRIB1 and TRIB3 are comparable in HSCs (Figure 2, 
3 and 5), which may indicate a positive regulatory relationship. Functionally 
there is a strong link between TRIBs and C/EBP family of transcription 
factors(48,49). Correlating the expression of TRIB1, TRIB2 and TRIB3 with 
C/EBPA, C/EBPB, C/EBPD and C/EBPE in normal cells, there is a positive 
correlation between TRIB1 and TRIB3 with all C/EBP members, and a negative 
correlation between TRIB2 and all C/EBP members (Figure 6Bi and Supplemental 
Figure S6). Moreover, in all the samples in the BloodPool and in myelodysplastic 
syndromes (MDS), significant negative correlations for TRIB1-TRIB2 and TRIB2-
TRIB3, and positive correlations for TRIB1-TRIB3 were found (Figure 6Aii-iii), 
and the correlations between TRIBs and C/EBP members are similar to those 
observed in normal cells (Figure 6Bii-iii). In acute lymphoid leukaemia (ALL), 
however, all three TRIBBLES were positively correlated with each other (Figure 
6Aiv), and with C/EBP members (Figure 6Biv), suggesting that an inverse 
relationship between TRIB1 and TRIB2 exists only in myeloid (MDS/AML) 
leukaemias. Therefore, we analysed the Log2 expression data of the TRIBBLES 
family in AML subtypes. We observed an inverse correlation of gene expression 
between TRIB1 and TRIB2 in several AML subtypes including normal karyotype 
(NK) and complex karyotype AML, samples with common chromosomal 
translocations, such as inv(16) CBFB/MYH11, t(15;17) PML/RARα, 11q23/MLL, 
t(8;21) AML1/ETO AML, and other AML with chromosomal aberrations, such as -
5/7q, -9q and Trisomy13 (although samples numbers were low in -9q and 
Trisomy13) (Supplemental Figure S4A-I). Conversely, a positive correlation was 
found between TRIB1 and TRIB3 expression across all samples in the BloodPool 
dataset, and in the NK, inv(16) CBFB/MYH11, t(15;17) PML/RARα AML, and in 
other aberrant cytogenetics groups such as Trisomy 13 and -5/7q subtypes. TRIB2 
and TRIB3 were inversely correlated only in AML samples with NK and -9q 
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(Supplemental Figure S4). Together, these data suggest that TRIB1 and TRIB2 
are inversely regulated in myeloid cells and in AML and suggests that they may 
have non-redundant, or even mutually exclusive roles in such conditions. 
Additionally, the positive correlation between TRIB1 and TRIB3 in several AML 
subtypes suggests a cooperative relationship. We hypothesize that upstream 
regulators in the different AML subtypes influence TRIB expression. Previously 
we published the putative transcription factors that bind to the 5’UTR of each 
TRIB gene(5), some proven experimentally(27,50). We show here that the 
expression of these transcription factors clearly correlates differently with each 
TRIB member. In normal cells, the bloodpool and MDS samples, but not the ALL 
samples, we see similar correlation profiles for TRIB1 and TRIB3, whereas the 
transcription factor correlation profile with TRIB2 is distinct (Figure 6C). 
Therefore, the putative upstream regulators of the TRIB genes cluster TRIB2 
distinct from TRIB1 and TRIB3, which may provide some explanation for the 
inverse and positive relationship between TRIB1-TRIB2 and TRIB1-TRIB3 
respectively.  
To gain more insight into the changes in expression in AML cells compared to 
normal cell expression levels, we assessed the expression patterns in the 
BloodPool vs Normal dataset, where the data from the BloodPool AML samples is 
provided after a further normalization level versus normal myeloid populations. 
Briefly, the expression from each individual AML sample in the BloodPool was 
batch corrected and normalised to that of the 5 nearest normal cells, according 
to Rapin’s cancer vs normal (CvN) method, which is based on a 2-step principal 
component analysis (PCA) strategy, and gene expression fold changes were 
computed(28,47). Using this approach, we show that the median Log2 fold 
change variations (hereafter referred to as FC) expression of TRIB1 is positive 
but actually only over a small range in AML samples compared to normal myeloid 
cells (between 2.7 and -0.7 FC) (Figure 7 and supplemental Figure S5). Of note 
however, t(15;17) PML/RARα AML has a median TRIB1 expression FC that is 
smaller to that of all major AML subgroups (e.g. inv(16) CBFB/MYH11, t(8;21) 
AML1/ETO, 11q23/MLL rearrangements, t(8;16) MOZ/CBP AML). The analyses of 
the normalised TRIB2 expression in several AML subtypes showed both positive 
and negative median FC values ranging from 3.2 and -2.8 (Figure 7 and 
supplemental Figure S5). Interestingly, TRIB1 and TRIB2 FC expression followed 
 
 
 11 
opposite trends in several leukaemia subtypes. Namely, AML samples with 
chromosome 9 translocations (t(6;9) DEK/NUP214, t(9;11) MLL/MLLT3 and 
t(9;22) BCR/ABL1 AML) exhibited the highest median TRIB1 expression FC 
amongst all the AML subtypes analysed, while they had a negative TRIB2 FC. 
Moreover, TRIB1/TRIB2 FC variations had an inverse direction (upregulated or 
downregulated, compared to normal myeloid cells) in MDS samples and in NK, 
t(8;21) AML1/ETO, t(11q23)/MLL rearrangements, t(8;16) MOZ/CBP, t(1;3) 
RPN1/PRDM16, del(9q) AML subtypes and samples with other AML translocations. 
In other aneuploidy cases, such as del(5q) AML, in complex karytotype AML and 
in ALL, both pseudokinases have increased expression, compared to normal 
myeloid cells (Figure 7 and supplemental Figure S5). Similar to our previous 
data, TRIB3 gene expression had a limited range of FC variation (-1.2 to 1.2 FC), 
with respect to normal myeloid cells. Of note and in contrast to TRIB1 and 
TRIB2, TRIB3 has higher FC expression in AML patients with t(15,17) PML/RARα 
than in the majority of other AML groups (Figure 7 and supplemental Figure 
S5), which is a subtype of AML where this positive FC analysis has proved to be 
functionally significant(23,51). To further support the inverse correlation 
between TRIB1 and TRIB2, we determined the Pearson r correlation coefficient 
of TRIBBLES FC gene expression in the AML subtypes vs Normal dataset (Figure 
8). Analyses of individual AML subtypes showed a significant negative correlation 
of TRIB1-TRIB2 FC in NK (Figure 8A), inv(16) CBFB/MYH11 (Figure 8B), t(15;17) 
PML/RARα (Figure 8C), 11q23/MLL (Figure 8D), -5/7(q) (Figure 8E), but not in 
t(8;21) AML1/ETO AML samples (Figure 8F). Moreover, significant positive 
correlations were found between TRIB1-TRIB3 in NK AML subtypes (Figure 8A) 
and inv(16) CBFB/MYH11 (Figure 8B), and a positive TRIB2-TRIB3 correlation in 
patients with 11q23/MLL rearrangements (Figure 8D). There is a disrupted 
profile of C/EBP expression in terms of correlation with TRIBBLES across the AML 
subtypes: it is more variable between the C/EBP family members in AMLs 
compared to the profile in normal cells, with the -5/7(q) subtype corresponding 
most closely to the normal profile (Supplemental Figure S7). 
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Discussion 
Overall, the evaluation of TRIBBLES expression, in both human and murine gene 
expression datasets, highlighted distinct lineage-specificities of the three 
pseudokinases during haemopoiesis. TRIB1 expression is higher in myeloid cells, 
compared to other haemopoietic compartments. TRIB2 gene expression is 
upregulated during thymocyte development, in B-cells, and progressively 
downregulated from MEPs during erythropoiesis. Trib3 gene expression whilst 
appearing to be over a small expression range may be important for HSC 
dormancy. Our data suggest an inverse relationship between TRIB1 and TRIB2 in 
the specification of different blood lineages inferred by their expression, and 
suggesting non-redundant lineage-specific functions during haemopoiesis. Our 
data also clearly link CEBP family members with the inverse relationship 
between TRIB1 and TRIB2. Additional transcription factors that bind to the 
different TRIB promoters may also contribute to the TRIB expression profile and 
their non-redundant functions. Without more data/samples of these populations 
we cannot reliably calculate correlation coefficients. These analyses are at 
steady state, and variations in expression levels may be altered in response to 
external stimulations, as in the case of lymphocyte activation.  
Our analyses using AML data suggest that multiple cytogenetic aberrations can 
lead to TRIBBLES deregulated expression compared to their normal counterparts, 
particularly TRIB1 and TRIB2. The inverse relationship between TRIB1 and TRIB2 
is evident across different AML subtypes suggesting they are likely regulated 
through different oncogenic pathways. Indeed, this could be explained by 
transcription factor regulation of their expression, as putative factors appeared 
to cluster TRIB1-TRIB3 distinct from TRIB2. There is an interesting clustering of 
PPARa transcription factor with a positive correlation with TRIB2 and a negative 
correlation with TRIB1 and TRIB3 in normal cells. Overexpression data has shown 
overlapping roles for TRIB1 and TRIB2 in AML(12,52,53). Therefore, the non-
redundancy of TRIB1 and TRIB2 in normal and malignant haemopoiesis is a 
necessary future line of functional investigation. Another possible explanation 
and not entirely mutually exclusive is that TRIB family members may be involved 
in regulating each other. Indeed a screen for protein interaction networks 
revealed the binding of TRIB2 to a previously validated E3 ligase target, COP1 
linking to TRIB degradation function, and interestingly, to TRIB1(54). These 
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results suggest the formation of multiprotein complexes and potential reciprocal 
regulation between TRIBBLES members. 
The generation of several strains of Trib1, Trib2 and Trib3 single KO mice (all 
able to reach adulthood) has been instrumental for studying the role of TRIBBLES 
in haemopoiesis(7,8,10,55-58). TRIB1-deficient mice exhibit abnormal 
differentiation of myeloid macrophage cells, with an increase in neutrophils and 
a decrease in macrophages observed in the BM and spleens of TRIB1 KO 
mice(8,56). In addition, TRIB1, TRIB2 and TRIB3 expression levels were shown to 
be dynamically controlled in response of inflammatory stimuli(59). The high 
expression of TRIB2 in the lymphoid and erythroid lineages match the current 
literature demonstrating a role for TRIB2 in lymphoid and erythroid 
development: TRIB2 deficient mice lack proper T cell differentiation(6), and 
TRIB2 is important for early stages of erythrocyte development(10). Matching 
these data, it was previously shown that TRIB2 is the downstream target of the 
master regulators of megakaryocytic and erythroid differentiation, FOG and 
GATA1, and shown to be downregulated in differentiating erythroblast cells(60). 
TRIB1 expression was absent in mature T-, B- and erythroid lineage cells, except 
for activated T-cell populations and in the CD4+FOXP3+CD25+ T-regulatory cells, 
which is in line with previously published data(61). The high similarity shared by 
three pseudokinases led to the hypothesis that compensatory mechanisms may 
be in place (at least in some cell types) in these murine models and mask some 
of the “deficient” phenotypes. The development of double and triple KO mice 
would therefore clarify the redundancy/non-redundancy in different cell types. 
Given the specific lineage distribution map of TRIB1, TRIB2 and TRIB3 defined by 
this study, it would be interesting to investigate whether deletion of one or two 
Tribbles would determine a redistribution of the other member(s) across the 
haemopoietic system. 
Despite the small range and variability in TRIB3 expression in normal and 
leukaemic cells, it is interesting that TRIB3 expression was higher in dormant 
HSCs which have the highest self-renewal potential compared to the active 
compartment(36). TRIB3 was identified as a negative regulator of the 
differentiation process of the haemangioblast (an early mesoderm precursor 
committed for haemopoiesis) into the haemopoietic progenitor cells (HPCs) (62). 
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Drosophila tribbles labels quiescent but not proliferating neural stem cells by 
promoting Cdc25string protein degradation during late embryogeneisis, and  
blocking activation of Akt in postembryonic neural stem cells(63), both 
mechanisms that have been linked with mammalian TRIBs(5,15). The role of 
TRIB3 in the adult HSC compartment has not yet been addressed and could 
represent a promising new field of investigation.  
Our expression data suggest that the dosage of individual TRIBBLES genes is 
differentially regulated in specific AML subtypes. The reason that different AML 
subtypes have different expression of TRIB family members may be explained by 
differences in the upstream regulators of each TRIB. TRIB1-3 promoter regions 
contain very different putative transcription factor binding sites(5). Indeed, the 
TRIB3 promoter has comparably less known transcription factor binding sites 
compared to TRIB1 and TRIB2 which may explain why TRIB3 has the tightest 
dynamic range of expression. It could be speculated that these changes in 
expression, compared to the normal context, and the ratio between the three 
TRIBBBLEs influence the pathophysiology of the resultant AML disease. When we 
compared the expression pattern of the TRIBBLES across the leukaemia samples 
studied, and evaluated the presence of gene correlations between the 
expression (and the expression FC) of each member we uncovered a clear 
negative correlation between TRIB1 and TRIB2 and a positive correlation 
between TRIB1 and TRIB3 expression in the pool of AML, ALL and MDS samples 
studied (BloodPool dataset). Interestingly, chromosome 9 translocations have 
the highest fold change variations in TRIB1 which warrants further investigation. 
Chromosome 9 translocation include the genes ABL, NUP, and AF9, which link to 
deregulated HOX expression and TRIB proteins have been shown to cooperate 
with HOX expression(64,65). Moreover, we found that TRIB1 and TRIB2 
expression are inversely correlated across several AML subtypes, suggesting that 
the two pseudokinases maintain an inverse regulation even in the cytogenetic 
groups where the expression of both genes was considered high (e.g.inv(16)) 
compared to other leukaemia subtypes. By analysing the correlations among 
TRIBBLES expression FC, from the BloodPool vs Normal dataset, we consistently 
found a negative correlation of the normalised expression of TRIB1 and TRIB2, in 
the pooled samples and amongst several AML subtypes. Given that the 
expression values of each sample in this analysis were normalised against the 
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nearest normal population (FC values), these results suggest that the correlation 
between TRIB1 and TRIB2 is not just a consequence of the differential expression 
of the two genes in the normal haemopoietic populations, mirrored in their 
malignant counterparts. Instead, these data clearly indicate that there is an 
opposite trend in the regulation of the two genes in malignant condition with 
respect to normal haemopoietic cells. 
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Methods 
The BloodSpot database was used to retrieve gene expression data from curated 
human and murine microarray and RNA-Sequencing (RNA-Seq) 
datasets(28)(Bagger et al. 2016) as summarised in Figure 1. Human and murine 
Trib1, Trib2 and Trib3 Log2 expression values were obtained from the BloodSpot 
database using the probes listed in Supplemental Table S1. These represent the 
probes with higher intensity in each analysis. Similarly, Log2 expression data for 
the relevant transcription factors were obtained using the probes listed in 
Supplemental Table S2. 
The expression values or the FC expression values exported from BloodSpot were 
then graphed using GraphPad Prism software. To calculate statistical 
significance, each population was compared to the values from all other 
populations in the chosen analysis, except the one studied e.g. in Figure 2 CD14+ 
monocytes have significantly different TRIB1 expression compared to the 
expression from all the other populations (data from all the haemopoietic cells, 
except CD14+ monocytes). Gene expression correlations were calculated and 
graphed using GraphPad Prism software. Correlation plots generated in R 
(v3.4.1) using the Corrplot package (v0.84); Pearson’s R correlations calculated 
using stats::cor() and p-value matrix generated using corrplot::cor.mtest() 
(v0.84); heatmaps (i.e., Figure 6c) were generated using the ComplexHeatmap 
package (v1.18.0) (66). Standard student t test was used for all comparisons and 
Welch’s correction applied when the variances between the tested groups were 
significantly different. 
GEO2R(NCBI n.d.) was used to retrieve Trib3 gene expression data from the 
microarray dataset GPL1261(36). This dataset comprises dormant or active LT-
HSC, defined respectively as label retaining and non-label retaining CD34-Lin-
Sca1+cKit+CD150+CD48- cells.  
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Figure legends 
Figure 1. Summary BloodSpot datasets analysed. RMA: Robust Multiarray 
Averaging method. CvN: Cancer vs Normal method(47). Briefly, each cancer 
sample was mapped onto the gene expression-based map of the normal 
haemopoietic hierarchy, based on a two-steps PCA method, and gene expression 
fold changes were computed against the weighted average expression value of 
the 5 nearest normal samples. Comparison of gene expression values is not 
possible amongst the selected datasets. ImmGen: Immunological Genome 
project, H: human, M: murine, SNo: number of samples, N: normalisation. For 
further details refer to (28). 
Figure 2. TRIBBLES expression in the human haemopoietic system. A) Log2 
expression of TRIB1, TRIB2 and TRIB3 in normal human haemopoietic cells; the 
hierarchical expression trees show the relationship between the samples 
displayed. Expression range is denoted by the colour key, as indicated. 
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Expression in different population is based on curated microarray data: Human 
HSC cells are from GSE17054(29); Human GMP, MEP cells are from GSE19599(30); 
Human Monocytes cells are from GSE11864(31) and E-MEXP-1242(32). The 
hierarchical plots were generated using the BloodSpot platform(28). B) Data in A 
graphed as box with maximum and minimum whiskers. Midlines represent 
median values, boxes represent 25th-75th percentiles. The highest (red) and 
lowest (blue) median expression are indicated by the horizontal dashed lines. 
Significant gene expression variation of each population compared to all the 
other samples studied is indicated by *P<0.05, **P<0.01, ***P<0.001, with Student 
T test (black stars), or T test with Welch’s correction for unequal variances (red 
stars).  
Figure 3. Tribbles expression in the murine haemopoietic system. Log2 
expression of Trib1 (A), Trib2 (B) and Trib3 (C) in normal murine haemopoietic 
cells. Expression in different population is based on curated microarray data 
from GSE14833(34) and GSE6506(35) (Table 2). Midlines represent median 
values. The highest (red) and lowest (blue) median expression are indicated by 
the horizontal dashed lines. Significant gene expression variation of each 
population compared to all the other samples studied is indicated by *P<0.05, 
**P<0.01, ***P<0.001, with Student T test (black stars), or T test with Welch’s 
correction for unequal variances (red stars). (D) TRIB3 expression levels in active 
and dormant LT-HSCs from microarray dataset GPL1261(36). *P<0.05, with 
Student T test. 
Figure 4. Tribbles expression in the mouse haemopoietic system from the 
ImmGen dataset.A) hierarchical expression plots of Trib1, Trib2 and Trib3 in 
normal murine haemopoietic cells, the plots were generated using the BloodSpot 
database; colour code denotes expression, the range is indicated for each gene. 
B) Aligned dot plots representing data in A. Midlines represent median values. 
The highest (red) and lowest (blue) median expression are indicated by the 
horizontal dashed lines. Significant gene expression variation of each population 
compared to all the other samples studied is indicated by *P<0.05, **P<0.01, 
***P<0.001, with Student T test (black stars), or T test with Welch’s correction 
for unequal variances (red stars). 
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Figure 5. TRIBBLES expression pattern is non-redundant in human AML 
subtypes. TRIBBLES Log2 expression in normal haemopoietic cell (left from the 
black dashed line), AML subtypes, MDS and ALL (BloodPool datasets(28)) (right 
from the black dashed line). Data is graphed as box with maximum and minimum 
whiskers. Midlines represent median values, boxes represent 25th-75th 
percentiles. The highest (red) and lowest (blue) median expression are indicated 
by the horizontal dashed lines. Significant gene expression variation of each 
population compared to all the other samples studied is indicated by *P<0.05, 
**P<0.01, ***P<0.001, with Student T test (black stars), or T test with Welch’s 
correction for unequal variances (red stars). 
Figure 6. TRIB1 and TRIB2 expression have an inverse correlation in human 
AML. (a) Correlation between TRIB1-TRIB2, TRIB2-TRIB3 and TRIB1-TRIB3 
expression in (i) normal haemopoietic cells, and in (ii) all AML, (iii) AML with 
MDS karyotype and (iv) ALL karyotype samples from the BloodPool dataset. 
Pearson’s r correlation coefficient is represented as a colour gradient as shown 
in the bottom right of the figure. Associated P values are indicated (*P<0.05). (b) 
Correlations (Pearson’s r) between TRIB1 (red), TRIB2 (blue) and TRIB3 (green) 
and the C/EBP family members (C/EBPα, C/EBPβ, C/EBPδ, C/EBPε) are 
summarized as boxplots for the same clinical cohorts as shown in (a). Specific 
family members are labelled in supplementary Figure S5. (c) Heatmaps showing 
correlation (as measured by Pearson’s r and coloured as in (a)) of TRIB1-3 with 
transcription factors known/predicted to influence expression of the TRIBBLES 
family. (i)-(iv) show these correlations for the same clinical cohorts shown in (a, 
b). The dendrogram to the left of each heatmap indicates similarity of 
correlation patterns of TRIB1-3. Columns represent the transcription factors of 
interest; these transcription factors are grouped into families using the colours 
shown on the top right hand side of the heatmaps. 
Figure 7. TRIBBLES exhibit different expression FC in human AML subtypes. 
TRIBBLES fold change expression normalised to normal myeloid cells(47) across 
several AML subtypes, MDS and ALL (BloodPool vs normal dataset(28)). Data is 
graphed as box with maximum and minimum whiskers. Midlines represent 
median values, boxes represent 25th-75th percentiles. The highest (red) and 
lowest (blue) median expression are indicated by the horizontal dashed lines. 
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Significant gene expression variation of each population compared to all the 
other samples studied is indicated by *P<0.05, **P<0.01, ***P<0.001, with Student 
T test (black stars), or T test with Welch’s correction for unequal variances (red 
stars). w denotes significant FC difference of median expression values 
compared to the baseline (0 FC), determined with Wilcoxon Signed Rank Test. 
Figure 8. TRIB1 and TRIB2 expression is inversely correlated in human 
AML.Correlation between TRIBBLES expression in the BloodPool vs normal 
dataset, specifically in NK AML and samples with the most common chromosomal 
translocations. Pearson’s r correlation coefficient is represented as a colour 
gradient as shown in the bottom right of the figure. Associated P values are 
indicated (*P<0.05). 
Figure 1
Click here to download high resolution image
Figure 2
Click here to download high resolution image
Figure 3
Click here to download high resolution image
Figure 4
Click here to download high resolution image
Figure 5
Click here to download high resolution image
Figure 6
Click here to download high resolution image
Figure 7
Click here to download high resolution image
Figure 8
Click here to download high resolution image
  
Supplemental Figure Legends
Click here to download Supplemental data: Supplemental Figure legends.docx
  
Supplemental Figure 1
Click here to download Supplemental data: SF1.jpg
  
Supplemental Figure 2
Click here to download Supplemental data: SF2.jpg
  
Supplemental Figure 3
Click here to download Supplemental data: SF3.jpg
  
Supplemental Figure 4
Click here to download Supplemental data: SF4.jpg
  
Supplemental Figure 5
Click here to download Supplemental data: SF5.jpg
  
Supplemental Figure 6
Click here to download Supplemental data: SF6.jpg
  
Supplemental Figure 7
Click here to download Supplemental data: SF7.jpg
  
Supplemental Table Legends
Click here to download Supplemental data: Supplemental Table legends.docx
  
Supplemental Table 1
Click here to download Supplemental data: Supplementary table 1.jpg
  
Supplemental Table 2
Click here to download Supplemental data: SupplementaryTable2.jpg
  
Supplemental Table 3
Click here to download Supplemental data: SupplementaryTable3.jpg
  
Supplemental Table 4
Click here to download Supplemental data: SupplementaryTable4.jpg
  
Supplemental Table 5
Click here to download Supplemental data: SupplementaryTable5.jpg
  
Supplemental Table 6
Click here to download Supplemental data: SupplementaryTable6.jpg
  
Supplemental Table 7
Click here to download Supplemental data: SupplementaryTable7.xlsx
